{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T21:29:00Z","timestamp":1785792540677,"version":"3.56.0"},"reference-count":46,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.3892\/etm.2016.3438","type":"journal-article","created":{"date-parts":[[2016,6,8]],"date-time":"2016-06-08T10:25:10Z","timestamp":1465381510000},"page":"1206-1212","source":"Crossref","is-referenced-by-count":16,"title":["Risk factors associated with secondary hyperparathyroidism in patients with chronic kidney disease"],"prefix":"10.3892","volume":"12","author":[{"given":"Yudan","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaonv","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujun","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,6,8]]},"reference":[{"key":"key20180108133334_b1-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1001\/jama.298.17.2038","article-title":"Prevalence of chronic kidney disease in the United States","volume":"298","author":"Coresh","year":"2007","journal-title":"JAMA"},{"key":"key20180108133334_b2-etm-0-0-3438","first-page":"161","article-title":"Centers for Disease Control and Prevention: Prevalence of chronic kidney disease and associated risk factors - United States, 1999\u20132004","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"key20180108133334_b3-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/sj.ki.5001542","article-title":"Changes in serum calcium, phosphate, and PTH and the risk of death in incident dialysis patients: A longitudinal study","volume":"70","author":"Melamed","year":"2006","journal-title":"Kidney Int"},{"key":"key20180108133334_b4-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/sj.ki.5002009","article-title":"Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: Results of the study to evaluate early kidney disease","volume":"71","author":"Levin","year":"2007","journal-title":"Kidney Int"},{"key":"key20180108133334_b5-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO): Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"key20180108133334_b6-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2215\/CJN.06040710","article-title":"Secondary hyperparathyroidism: Pathogenesis, disease progression, and therapeutic options","volume":"6","author":"Cunningham","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"key20180108133334_b7-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"18","DOI":"10.4158\/EP.14.1.18","article-title":"Management of secondary hyperparathyroidism in stages 3 and 4 chronic kidney disease","volume":"14","author":"Andress","year":"2008","journal-title":"Endocr Pract"},{"key":"key20180108133334_b8-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s00774-006-0719-7","article-title":"The kidney and bone metabolism: Nephrologists' point of view","volume":"24","author":"Fukagawa","year":"2006","journal-title":"J Bone Miner Metab"},{"key":"key20180108133334_b9-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/ndt\/gfs598","article-title":"Correlates of parathyroid hormone concentration in hemodialysis patients","volume":"28","author":"Li","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108133334_b10-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J Biol Chem"},{"key":"key20180108133334_b11-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"key20180108133334_b12-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"issue":"S73","key":"key20180108133334_b13-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1046\/j.1523-1755.1999.07304.x","article-title":"Pathogenesis of secondary hyperparathyroidism","volume":"73","author":"Slatopolsky","year":"1999","journal-title":"Kidney Int Suppl"},{"key":"key20180108133334_b14-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2011.05.005","article-title":"Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors?","volume":"162","author":"Anderson","year":"2011","journal-title":"Am Heart J"},{"issue":"4 Suppl 3","key":"key20180108133334_b15-etm-0-0-3438","first-page":"S1","article-title":"National Kidney Foundation: K\/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease","volume":"42","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"key20180108133334_b16-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1093\/clinchem\/35.11.2233","article-title":"An improved pyrogallol red-molybdate method for determining total urinary protein","volume":"35","author":"Orsonneau","year":"1989","journal-title":"Clin Chem"},{"key":"key20180108133334_b17-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1523-1755.2005.67139.x","article-title":"Achieving NKF-K\/DOQI bone metabolism and disease treatment goals with cinacalcet HCl","volume":"67","author":"Moe","year":"2005","journal-title":"Kidney Int"},{"key":"key20180108133334_b18-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/ajcp\/100.2.123","article-title":"An evaluation of hemoglobin determination using sodium lauryl sulfate","volume":"100","author":"Karsan","year":"1993","journal-title":"AmJ Clin Pathol"},{"key":"key20180108133334_b19-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1681\/ASN.V1161141","article-title":"Cell biology of parathyroid gland hyperplasia in chronic renal failure","volume":"11","author":"Dr\u00fceke","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"key20180108133334_b20-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/edrv-15-3-301","article-title":"Counterpoint: Estrogen effects on calcitropic hormones and calcium homeostasis","volume":"15","author":"Prince","year":"1994","journal-title":"Endocr Rev"},{"key":"key20180108133334_b21-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/j.1523-1755.2004.00837.x","article-title":"Epidemiologic data of renal diseases from a single unit in China: analysis based on 13,519 renal biopsies","volume":"66","author":"Li","year":"2004","journal-title":"Kidney Int"},{"key":"key20180108133334_b22-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"e3013","DOI":"10.1097\/MD.0000000000003013","article-title":"Risk factors for development and progression of chronic kidney disease: A systematic review and exploratory meta-analysis","volume":"95","author":"Tsai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"key20180108133334_b23-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOP.0b013e328336ebb0","article-title":"Risk factors for progression of chronic kidney disease","volume":"22","author":"Staples","year":"2010","journal-title":"Curr Opin Pediatrics"},{"key":"key20180108133334_b24-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0735-1097(02)01717-5","article-title":"Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension","volume":"39","author":"Ferrier","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"key20180108133334_b25-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1053\/j.ackd.2011.01.001","article-title":"The roles of the skeleton and phosphorus in the CKD mineral bone disorder","volume":"18","author":"Hruska","year":"2011","journal-title":"Adv Chronic Kidney Dis"},{"key":"key20180108133334_b26-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1093\/ndt\/gfm286","article-title":"PREPARE study group: High plasma phosphate as a risk factor for decline in renal function and mortality in pre-dialysis patients","volume":"22","author":"Voormolen","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108133334_b27-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/sj.ki.5002287","article-title":"Development and progression of secondary hyperparathyroidism in chronic kidney disease: Lessons from molecular genetics","volume":"74","author":"Goodman","year":"2008","journal-title":"Kidney Int"},{"key":"key20180108133334_b28-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1001\/archinte.166.10.1134","article-title":"Serum urea nitrogen, creatinine, and estimators of renal function: mortality in older patients with cardiovascular disease","volume":"166","author":"Smith","year":"2006","journal-title":"Arch Intern Med"},{"issue":"Suppl 113","key":"key20180108133334_b29-etm-0-0-3438","first-page":"S1","article-title":"Kidney Disease; Improving Global Outcomes (KDIGO)CKD-MBD Work Group: KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)","volume":"76","year":"2009","journal-title":"Kidney Int"},{"key":"key20180108133334_b30-etm-0-0-3438","first-page":"724","article-title":"Metabolic acidosis and progression of chronic kidney disease: incidence, pathogenesis, and therapeutic options","volume":"32","author":"Ortega","year":"2012","journal-title":"Nefrologia"},{"key":"key20180108133334_b31-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/ndt\/gfs291","article-title":"Metabolic acidosis and kidney disease: does bicarbonate therapy slow the progression of CKD?","volume":"27","author":"Kovesdy","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108133334_b32-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1523-1755.2002.kid568.x","article-title":"Metabolic acidosis up-regulates PTH\/PTHrP receptors in UMR 106-01 osteoblast-like cells","volume":"62","author":"Disthabanchong","year":"2002","journal-title":"Kidney Int"},{"key":"key20180108133334_b33-etm-0-0-3438","first-page":"33","article-title":"Inflammation markers, chronic kidney disease, and renal replacement therapy","volume":"27","author":"Lav\u00edn-G\u00f3mez","year":"2011","journal-title":"Adv Perit Dial"},{"key":"key20180108133334_b34-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1159\/000075809","article-title":"Exploring inflammation in hemodialysis patients: Persistent and superimposed inflammation. A longitudinal study","volume":"27","author":"Tsirpanlis","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"key20180108133334_b35-etm-0-0-3438","first-page":"583","article-title":"Chronic microinflammation and endothelial damage in uremia","volume":"28","author":"Ojeda","year":"2008","journal-title":"Nefrologia"},{"key":"key20180108133334_b36-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.diabres.2004.01.003","article-title":"Oolong tea increases plasma adiponectin levels and low-density lipoprotein particle size in patients with coronary artery disease","volume":"65","author":"Shimada","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"key20180108133334_b37-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/sj.ki.5002481","article-title":"Anemia as a risk factor for chronic kidney disease","author":"Iseki","year":"2007","journal-title":"Kidney Int Suppl"},{"key":"key20180108133334_b38-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1159\/000186596","article-title":"Serum erythropoietin and erythropoiesis in primary and secondary hyperparathyroidism: Effect of parathyroidectomy","volume":"59","author":"Urena","year":"1991","journal-title":"Nephron"},{"issue":"Suppl 5","key":"key20180108133334_b39-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1093\/ndt\/17.suppl_5.28","article-title":"Role of secondary hyperparathyroidism in erythropoietin resistance of chronic renal failure patients","volume":"17","author":"Dr\u00fceke","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"key20180108133334_b40-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1681\/ASN.2006050420","article-title":"Renal fibroblasts and myofibroblasts in chronic kidney disease","volume":"17","author":"Strutz","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key20180108133334_b41-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0272-6386(12)80030-8","article-title":"Lipoprotein metabolism and renal failure","volume":"21","author":"Attman","year":"1993","journal-title":"Am J Kidney Dis"},{"key":"key20180108133334_b42-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","article-title":"Renal lipid metabolism and lipotoxicity","volume":"19","author":"Bobulescu","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"key20180108133334_b43-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1681\/ASN.2006010012","article-title":"Statins for improving renal outcomes: A meta-analysis","volume":"17","author":"Sandhu","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"key20180108133334_b44-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1523-1755.61.s80.20.x","article-title":"Oxidative stress in hemodialysis patients: Is NADPH oxidase complex the culprit?","volume":"61","author":"Morena","year":"2002","journal-title":"Kidney Int Suppl"},{"key":"key20180108133334_b45-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.semnephrol.2009.01.002","article-title":"Chronic kidney disease\/bone and mineral metabolism: the imperfect storm","volume":"29","author":"Williams","year":"2009","journal-title":"Semin Nephrol"},{"key":"key20180108133334_b46-etm-0-0-3438","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/039139880903200208","article-title":"Calcimimetics in the chronic kidney disease-mineral and bone disorder","volume":"32","author":"Bover","year":"2009","journal-title":"Int J Artif Organs"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2016.3438\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T05:58:34Z","timestamp":1656655114000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2016.3438"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,8]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6,8]]},"published-print":{"date-parts":[[2016,8]]}},"alternative-id":["10.3892\/etm.2016.3438"],"URL":"https:\/\/doi.org\/10.3892\/etm.2016.3438","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,8]]}}}